Implantable Cardioverter-Defibrillator Registry Risk Score Models for Acute Procedural Complications or Death After Implantable Cardioverter-Defibrillator Implantation

被引:70
|
作者
Haines, David E. [1 ]
Wang, Yongfei [2 ]
Curtis, Jeptha [2 ]
机构
[1] Oakland Univ, Dept Cardiovasc Med, William Beaumont Sch Med, Beaumont Hosp,Heart Rhythm Ctr, Royal Oak, MI 48073 USA
[2] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA
关键词
complications; death; implantable cardioverter-defibrillators; outcome assessment; registries; MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL; PACEMAKER; OUTCOMES;
D O I
10.1161/CIRCULATIONAHA.110.959676
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Patients undergoing implantable cardioverter-defibrillator (ICD) implantation are at risk of postprocedural complications. However, we do not have a risk stratification schema to identify patients at high and low risk of adverse events. Methods and Results-We analyzed data from 268 701 ICD implants submitted to the ICD Registry and developed logistic regression models to identify variables most strongly associated with the risk of acute complications and/or in-hospital death. Overall, 3.2% of the population experienced an adverse event. A simple risk score consisting of 10 readily available variables successfully identified patients at high and low risk of complications. The variables included in the score and assigned points included: age >= 70 years (1 point), female (2 points), New York Heart Association class III (1 point) or IV (3 points), atrial fibrillation (1 point), prior valve surgery (3 points), chronic lung disease (2 points), blood urea nitrogen >30 (2 points), reimplantation for reasons other than battery change (6 points), ICD type dual chamber (2 points) or biventricular (4 points), and nonelective ICD implant (3 points). The risk of any in-hospital complication increased from 0.6% among patients with a score of <= 5 (8.4% of the population) to 8.4% among patients with >= 19 risk points (3.9% of the population). Conclusions-A simple risk score consisting of readily available clinical variables can identify high-and low-risk subsets of patients undergoing ICD implantation. This information can guide the physician in patient selection and determining the intensity of care required post procedure. (Circulation. 2011;123:2069-2076.)
引用
收藏
页码:2069 / 2076
页数:8
相关论文
共 50 条
  • [1] The Relation Between Hospital Procedure Volume and Complications of Cardioverter-Defibrillator Implantation From the Implantable Cardioverter-Defibrillator Registry
    Freeman, James V.
    Wang, Yongfei
    Curtis, Jeptha P.
    Heidenreich, Paul A.
    Hlatky, Mark A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (14) : 1133 - 1139
  • [2] Survival After Implantable Cardioverter-Defibrillator Implantation in the Elderly
    Yung, Derek
    Birnie, David
    Dorian, Paul
    Healey, Jeffrey S.
    Simpson, Christopher S.
    Crystal, Eugene
    Krahn, Andrew D.
    Khaykin, Yaariv
    Cameron, Douglas
    Chen, Zhongliang
    Lee, Douglas S.
    CIRCULATION, 2013, 127 (24) : 2383 - 2392
  • [3] The subcutaneous implantable cardioverter-defibrillator
    Grace, Andrew
    CURRENT OPINION IN CARDIOLOGY, 2014, 29 (01) : 10 - 19
  • [4] Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator
    Klein, Helmut U.
    Goldenberg, Ilan
    Moss, Arthur J.
    EUROPEAN HEART JOURNAL, 2013, 34 (29) : 2230 - 2242
  • [5] Survival After Implantable Cardioverter-Defibrillator Shocks
    Aktas, Mehmet K.
    Younis, Arwa
    Zareba, Wojciech
    Kutyifa, Valentina
    Klein, Helmut
    Daubert, James P.
    Estes, Mark
    McNitt, Scott
    Polonsky, Bronislava
    Goldenberg, Ilan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (20) : 2453 - 2462
  • [6] Active Surveillance of the Implantable Cardioverter-Defibrillator Registry for Defibrillator Lead Failures
    Resnic, Frederic S.
    Majithia, Arjun
    Dhruva, Sanket S.
    Ssemaganda, Henry
    Robbins, Susan
    Marinac-Dabic, Danica
    Hewitt, Kathleen
    Ohno-Machado, Lucila
    Reynolds, Matthew R.
    Matheny, Michael E.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2020, 13 (04):
  • [7] Subcutaneous Implantable Cardioverter-Defibrillator Technology
    Gupta, Anurag
    Al-Ahmad, Amin
    Wang, Paul J.
    HEART FAILURE CLINICS, 2011, 7 (02) : 287 - +
  • [8] Hypertrophic cardiomyopathy and the implantable cardioverter-defibrillator
    Manovel-Sanchez, Ana J.
    Pedrote-Martinez, Alonso
    Arana-Rueda, Eduardo
    de Tejada, Francisco Errazquin-Saenz
    REVISTA ESPANOLA DE CARDIOLOGIA, 2007, 60 (07): : 784 - 784
  • [9] Shock Without Wires: A Look at Subcutaneous Implantable Cardioverter-Defibrillator Compared to Transvenous Implantable Cardioverter-Defibrillator for Ventricular Arrhythmias
    Raja, Joel
    Guice, Kenneth
    Oberoi, Mansi
    Whitwell, Samantha
    Asbeutah, Abdul Aziz
    Russell, Alex
    Khouzam, Rami N.
    CURRENT PROBLEMS IN CARDIOLOGY, 2022, 47 (09)
  • [10] MORTALITY BENEFITS AND THE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    SWEENEY, MO
    RUSKIN, JN
    CIRCULATION, 1994, 89 (04) : 1851 - 1858